ATE334679T1 - Feste oral anzuwendende arzneizubereitung mit gesteuerter wirkstoffabgabe enthaltend eine säureempfindliche benzimidazolverbindung - Google Patents
Feste oral anzuwendende arzneizubereitung mit gesteuerter wirkstoffabgabe enthaltend eine säureempfindliche benzimidazolverbindungInfo
- Publication number
- ATE334679T1 ATE334679T1 AT00500203T AT00500203T ATE334679T1 AT E334679 T1 ATE334679 T1 AT E334679T1 AT 00500203 T AT00500203 T AT 00500203T AT 00500203 T AT00500203 T AT 00500203T AT E334679 T1 ATE334679 T1 AT E334679T1
- Authority
- AT
- Austria
- Prior art keywords
- acid
- solid oral
- medicinal preparation
- benzimidazole compound
- active release
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES009902027A ES2168043B1 (es) | 1999-09-13 | 1999-09-13 | Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido. |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE334679T1 true ATE334679T1 (de) | 2006-08-15 |
Family
ID=8309905
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00500203T ATE334679T1 (de) | 1999-09-13 | 2000-09-13 | Feste oral anzuwendende arzneizubereitung mit gesteuerter wirkstoffabgabe enthaltend eine säureempfindliche benzimidazolverbindung |
Country Status (12)
Country | Link |
---|---|
US (1) | US6780436B1 (de) |
EP (1) | EP1086694B1 (de) |
JP (1) | JP4885347B2 (de) |
KR (1) | KR100724201B1 (de) |
AT (1) | ATE334679T1 (de) |
AU (1) | AU777322B2 (de) |
CA (1) | CA2318008C (de) |
CY (1) | CY1106219T1 (de) |
DE (1) | DE60029712T2 (de) |
DK (1) | DK1086694T3 (de) |
ES (2) | ES2168043B1 (de) |
PT (1) | PT1086694E (de) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8101209B2 (en) | 2001-10-09 | 2012-01-24 | Flamel Technologies | Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
ES2198195B1 (es) * | 2001-12-18 | 2004-10-01 | Laboratorios Del Dr. Esteve, S.A. | Forma de dosificacion farmaceutica oral comprimida, con recubrimiento enterico, que contiene un compuesto de bencimidazol labil en medio acido. |
CN100553625C (zh) | 2002-04-09 | 2009-10-28 | 弗拉梅技术公司 | 活性成分微囊的口服混悬液 |
ATE407674T1 (de) | 2002-04-09 | 2008-09-15 | Flamel Tech Sa | Orale pharmazeutische formulierung in form einer wässrigen suspension von mikrokapseln zur modifizierten freisetzung von amoxicillin |
ES2534713T3 (es) * | 2002-10-16 | 2015-04-27 | Takeda Pharmaceutical Company Limited | Preparaciones sólidas estables |
MY148805A (en) | 2002-10-16 | 2013-05-31 | Takeda Pharmaceutical | Controlled release preparation |
WO2004098573A1 (en) * | 2003-05-08 | 2004-11-18 | Natco Pharma Limited | An improved and stable pharmaceutical composition containing substituted benzimidazoles and a process for its preparation |
US20050013863A1 (en) * | 2003-07-18 | 2005-01-20 | Depomed, Inc., A Corporation Of The State Of California | Dual drug dosage forms with improved separation of drugs |
TWI372066B (en) | 2003-10-01 | 2012-09-11 | Wyeth Corp | Pantoprazole multiparticulate formulations |
AU2003272086A1 (en) * | 2003-10-14 | 2005-04-27 | Natco Pharma Limited | Enteric coated pellets comprising esomeprazole, hard gelatin capsule containing them, and method of preparation |
FR2861990B1 (fr) * | 2003-11-10 | 2006-02-10 | Nouveaux Produits Pharma | Comprimes faiblement doses a reseau de polymeres |
EP1768668A2 (de) | 2004-06-16 | 2007-04-04 | Tap Pharmaceutical Products, Inc. | Multi-ppi-dosierform |
AR051654A1 (es) * | 2004-11-04 | 2007-01-31 | Astrazeneca Ab | Nuevas formulaciones de pellets de liberacion modificada para inhibidores de la bomba de protones |
AR052225A1 (es) * | 2004-11-04 | 2007-03-07 | Astrazeneca Ab | Formulaciones de tabletas de liberacion modificada par inhibidores de la bomba de protones |
US20060210637A1 (en) * | 2005-03-17 | 2006-09-21 | Qpharma, Llc | Stable tablet dosage forms of proton pump inhibitors |
US20070015782A1 (en) | 2005-04-15 | 2007-01-18 | Eisai Co., Ltd. | Benzimidazole compound |
WO2006111853A2 (en) * | 2005-04-18 | 2006-10-26 | Aurobindo Pharma Limited | Stable solid dosage forms of acid labile drug |
JP5118962B2 (ja) * | 2005-04-28 | 2013-01-16 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 安定化組成物 |
US9040564B2 (en) | 2005-04-28 | 2015-05-26 | Eisai R&D Management Co., Ltd. | Stabilized composition |
EP1880718B1 (de) * | 2006-07-10 | 2011-09-21 | Dr. R. Pfleger Chemische Fabrik GmbH | Pharmazeutische Zubereitung für die orale Verabreichung mit gesteuerter Wirkstofffreisetzung im Dünndarm und Verfahren zu ihrer Herstellung |
EP2319504A1 (de) | 2009-11-07 | 2011-05-11 | Laboratorios Del. Dr. Esteve, S.A. | Feste pharmazeutische Dosierform |
RU2647472C2 (ru) | 2011-11-02 | 2018-03-15 | Лабораторьос Дель Др. Эстеве, С.А. | Фармацевтическая композиция омепразола |
WO2013111149A1 (en) * | 2011-12-21 | 2013-08-01 | Hetero Research Foundation | Controlled release solid oral compositions of dexlansoprazole |
CN103202820B (zh) * | 2012-01-11 | 2016-03-30 | 浙江亚太药业股份有限公司 | 一种稳定的兰索拉唑肠溶胶囊及其制备方法 |
CN104586809A (zh) * | 2015-01-08 | 2015-05-06 | 浙江亚太药业股份有限公司 | 一种埃索美拉唑镁微丸肠溶片及制备方法 |
EP3288556A4 (de) | 2015-04-29 | 2018-09-19 | Dexcel Pharma Technologies Ltd. | Oral zerfallende zusammensetzungen |
WO2017145146A1 (en) | 2016-02-25 | 2017-08-31 | Dexcel Pharma Technologies Ltd. | Compositions comprising proton pump inhibitors |
US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
US11504395B2 (en) * | 2016-09-15 | 2022-11-22 | Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis | Oral pyrophosphate for use in reducing tissue calcification |
KR20200005576A (ko) * | 2017-05-17 | 2020-01-15 | 컨플루언스 파마슈티컬스, 엘엘씨 | 호모타우린 및 이의 염의 제형 |
Family Cites Families (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB829055A (en) | 1958-02-07 | 1960-02-24 | Charles E Frosst And Company | Improvements in or relating to pharmaceutical preparations |
US4150111A (en) | 1974-05-28 | 1979-04-17 | Allister Warren | Enteric coated magnesium chloride |
JPS5837285B2 (ja) | 1975-05-29 | 1983-08-15 | カブシキガイシヤ ミドリジユウジ | チヨウナイカンセンシヨウチリヨウザイノセイゾウホウホウ |
JPS5598120A (en) | 1979-01-16 | 1980-07-25 | Shin Etsu Chem Co Ltd | Preparation of drug having enteric coating |
US4470980A (en) | 1980-03-07 | 1984-09-11 | Interx Research Corp. | Method of increasing oral absorption of β-lactam antibiotics |
JPS57208155A (en) | 1981-06-17 | 1982-12-21 | Toshiba Corp | Detecting method for pinhole |
US4377568A (en) | 1981-08-12 | 1983-03-22 | Merck Sharp & Dohme (I.A.) Corp. | Preparation of aqueous alcoholic dispersions of pH sensitive polymers and plasticizing agents and a method of enteric coating dosage forms using same |
JPS59193831A (ja) | 1983-04-18 | 1984-11-02 | Sankyo Co Ltd | 腸溶性製剤の製造法 |
GB2189698A (en) | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
GB2189699A (en) | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated acid-labile medicaments |
US5026560A (en) | 1987-01-29 | 1991-06-25 | Takeda Chemical Industries, Ltd. | Spherical granules having core and their production |
JPH0774166B2 (ja) * | 1987-02-06 | 1995-08-09 | 信越化学工業株式会社 | 徐放性被覆薬剤の製造方法 |
JPH0768125B2 (ja) * | 1988-05-18 | 1995-07-26 | エーザイ株式会社 | 酸不安定化合物の内服用製剤 |
US5133974A (en) * | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
GB8913889D0 (en) * | 1989-06-16 | 1989-08-02 | May & Baker Ltd | New compositions of matter |
US5395611A (en) | 1990-04-24 | 1995-03-07 | The Governors Of The University Of Alberta | Phenolic amine depigmenting and antimelanoma agents |
US5232706A (en) | 1990-12-31 | 1993-08-03 | Esteve Quimica, S.A. | Oral pharmaceutical preparation containing omeprazol |
GB2256587A (en) * | 1991-06-11 | 1992-12-16 | American Cyanamid Co | Acetazolamide in sustained release form |
YU48263B (sh) | 1991-06-17 | 1997-09-30 | Byk Gulden Lomberg Chemische Fabrik Gmbh. | Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola |
ATE156707T1 (de) | 1991-06-21 | 1997-08-15 | Ilsan Ilac Ve Hammaddeleri San | Neues galenisches verfahren für omeprazol enthaltende pellets |
JPH05255088A (ja) * | 1991-11-05 | 1993-10-05 | Yoshitomi Pharmaceut Ind Ltd | 抗潰瘍剤含有製剤 |
JPH05194225A (ja) * | 1991-11-07 | 1993-08-03 | Yoshitomi Pharmaceut Ind Ltd | 安定化された抗潰瘍剤含有製剤 |
JPH09500645A (ja) * | 1993-07-22 | 1997-01-21 | ワーナー−ランバート・コンパニー | 制御放出タクリン薬物送達システムおよびその製造方法 |
CN1138534C (zh) | 1994-07-08 | 2004-02-18 | 阿斯特拉曾尼卡有限公司 | 多单元片剂 |
SE9402431D0 (sv) | 1994-07-08 | 1994-07-08 | Astra Ab | New tablet formulation |
ES2094694B1 (es) * | 1995-02-01 | 1997-12-16 | Esteve Quimica Sa | Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion. |
US5558879A (en) * | 1995-04-28 | 1996-09-24 | Andrx Pharmaceuticals, Inc. | Controlled release formulation for water soluble drugs in which a passageway is formed in situ |
US5945124A (en) * | 1995-07-05 | 1999-08-31 | Byk Gulden Chemische Fabrik Gmbh | Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole |
WO1997004752A1 (en) * | 1995-07-26 | 1997-02-13 | Duramed Pharmaceuticals, Inc. | Pharmaceutical compositions of conjugated estrogens and methods for their use |
DK0859612T3 (da) * | 1995-09-21 | 2003-09-22 | Pharma Pass Ii Llc | Farmaceutisk sammensætning indeholdende en syre-labil omeprazol og fremgangsmåde til fremstilling deraf |
SE9603667D0 (sv) * | 1996-10-08 | 1996-10-08 | Astra Ab | Pharmaceutical compositions |
JP2762998B2 (ja) * | 1997-04-25 | 1998-06-11 | 武田薬品工業株式会社 | 医薬固形組成物用安定化剤および安定化方法 |
GB9710800D0 (en) | 1997-05-23 | 1997-07-23 | Cipla Limited | Pharmaceutical composition and method of preparing it |
GB9710699D0 (en) | 1997-05-24 | 1997-07-16 | Danbiosyst Uk | Gastro-retentive controlled release system |
SE9702000D0 (sv) | 1997-05-28 | 1997-05-28 | Astra Ab | New pharmaceutical formulation |
AU727152B2 (en) * | 1997-07-01 | 2000-12-07 | Pfizer Products Inc. | Delayed-release dosage forms of sertraline |
SE9702533D0 (sv) * | 1997-07-01 | 1997-07-01 | Astra Ab | New oral formulation |
SI9700186B (sl) * | 1997-07-14 | 2006-10-31 | Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. | Nova farmacevtska oblika z nadzorovanim sproscanjem zdravilnih ucinkovin |
US5965167A (en) * | 1997-10-07 | 1999-10-12 | Sanghvi; Pradeepkumar P. | Dosage units |
US6096340A (en) | 1997-11-14 | 2000-08-01 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
US6174548B1 (en) | 1998-08-28 | 2001-01-16 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
DK173431B1 (da) | 1998-03-20 | 2000-10-23 | Gea Farmaceutisk Fabrik As | Farmaceutisk formulering omfattende en 2-[[(2-pyridinyl)methyl]sulfinyl]benzimidazol med anti-ulcusaktivitet samt fremgangs |
ZA9810765B (en) | 1998-05-28 | 1999-08-06 | Ranbaxy Lab Ltd | Stable oral pharmaceutical composition containing a substituted pyridylsulfinyl benzimidazole. |
US6166213A (en) | 1998-08-11 | 2000-12-26 | Merck & Co., Inc. | Omeprazole process and compositions thereof |
SE9803772D0 (sv) | 1998-11-05 | 1998-11-05 | Astra Ab | Pharmaceutical formulation |
-
1999
- 1999-09-13 ES ES009902027A patent/ES2168043B1/es not_active Expired - Fee Related
-
2000
- 2000-09-12 US US09/660,022 patent/US6780436B1/en not_active Expired - Lifetime
- 2000-09-12 AU AU57919/00A patent/AU777322B2/en not_active Ceased
- 2000-09-12 CA CA2318008A patent/CA2318008C/en not_active Expired - Fee Related
- 2000-09-13 ES ES00500203T patent/ES2269088T3/es not_active Expired - Lifetime
- 2000-09-13 PT PT00500203T patent/PT1086694E/pt unknown
- 2000-09-13 DE DE60029712T patent/DE60029712T2/de not_active Expired - Lifetime
- 2000-09-13 EP EP00500203A patent/EP1086694B1/de not_active Expired - Lifetime
- 2000-09-13 JP JP2000277838A patent/JP4885347B2/ja not_active Expired - Fee Related
- 2000-09-13 DK DK00500203T patent/DK1086694T3/da active
- 2000-09-13 AT AT00500203T patent/ATE334679T1/de active
- 2000-09-14 KR KR1020000053939A patent/KR100724201B1/ko not_active IP Right Cessation
-
2006
- 2006-10-25 CY CY20061101540T patent/CY1106219T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
PT1086694E (pt) | 2006-12-29 |
DK1086694T3 (da) | 2006-12-04 |
EP1086694A2 (de) | 2001-03-28 |
JP4885347B2 (ja) | 2012-02-29 |
DE60029712T2 (de) | 2007-08-02 |
ES2168043A1 (es) | 2002-05-16 |
US6780436B1 (en) | 2004-08-24 |
CA2318008C (en) | 2010-08-17 |
KR100724201B1 (ko) | 2007-05-31 |
EP1086694B1 (de) | 2006-08-02 |
KR20020020974A (ko) | 2002-03-18 |
ES2168043B1 (es) | 2003-04-01 |
CY1106219T1 (el) | 2011-06-08 |
ES2269088T3 (es) | 2007-04-01 |
AU5791900A (en) | 2001-03-15 |
CA2318008A1 (en) | 2001-03-13 |
JP2001199878A (ja) | 2001-07-24 |
DE60029712D1 (de) | 2006-09-14 |
AU777322B2 (en) | 2004-10-14 |
EP1086694A3 (de) | 2002-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE334679T1 (de) | Feste oral anzuwendende arzneizubereitung mit gesteuerter wirkstoffabgabe enthaltend eine säureempfindliche benzimidazolverbindung | |
ES2209240T3 (es) | Formas de dosificacion farmaceutica oral de liberacion por pulsos. | |
JP4638964B2 (ja) | プロトンポンプ阻害剤およびnsaidからなる経口用医薬剤形 | |
ES2244167T3 (es) | Nuevas preparaciones farmaceuticas multiunitarias estables que contienen bencimidazoles sustituidos. | |
ES2201200T3 (es) | Composicion farmaceutica que contiene un omeprazol labil al acido, y procedimiento para su preparacion. | |
ES2316333T3 (es) | Forma de dosificacion en tabletas constituida por unidades multiples. | |
RU2340358C2 (ru) | Композиция, ингибирующая секрецию кислоты в желудке | |
FI122016B (fi) | Protonipumppuinhibiittoria sisältävä farmaseuttinen moniyksikköpreparaatti | |
US6228400B1 (en) | Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same | |
CA2258918C (en) | Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof | |
US20070048380A1 (en) | Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof | |
JP2006505566A5 (de) | ||
SA99191077B1 (ar) | صورة لجرعة صيدلانية طويلة المفعول تعطى عن طريق الفم | |
BRPI0309142B1 (pt) | 20120040114 suspensão de microcápsulas em uma fase líquida aquosa, que permite a liberação modificada de pelo menos um princípio ativo com exclusão da amoxicilina e que é destinada a ser administrada por via oral | |
ZA200109803B (en) | New formulation. | |
WO2006040779A3 (en) | Controlled release gastric floating matrix formulation containing imatinib | |
JP6289367B2 (ja) | 有核錠 | |
Johnson et al. | Esomeprazole: a clinical review | |
EP0983067A1 (de) | Benzimidazole enthaltende zusammensetzung und verfahren zu deren herstellung | |
JP2002525266A5 (de) | ||
ATE410149T1 (de) | Komprimierte, orale pharmazeutische dosierungsform mit enterischer beschichtung, die eine säurelabile benzimidazolverbindung enthält | |
US20010053387A1 (en) | Benzimidazole pharmaceutical composition and process of prepatation | |
WO2013122554A1 (en) | Pellet formulations comprising esomeprazole | |
ES2394888B1 (es) | Forma farmacéutica de liberación modificada de dexketoprofeno e inhibidor de la bomba de protones y uso de la misma. | |
TR201723199A2 (tr) | Yeni farmasötik bileşimler. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1086694 Country of ref document: EP |